{"pmid":32259402,"title":"Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan.","text":["Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan.","Cancer Cytopathol","Chen, Chien-Chin","Chi, Chia-Yu","32259402"],"journal":"Cancer Cytopathol","authors":["Chen, Chien-Chin","Chi, Chia-Yu"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259402","week":"202015|Apr 06 - Apr 12","doi":"10.1002/cncy.22280","keywords":["COVID-19","biosafety","coronavirus","cytology","pneumonia"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1663450393450905600,"score":7.9164424,"similar":[{"pmid":32259373,"title":"Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An italian institutional experience focusing on biosafety procedures.","text":["Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An italian institutional experience focusing on biosafety procedures.","The 2019 coronavirus pandemic, which started in Wuhan, China, spread around the globe with dramatic and lethal effects. From the initial Chinese epicenter, the European diaspora taxed the resources of several countries and especially those of Italy, which was forced into a complete social and economic shutdown. Infection by droplets contaminating hands and surfaces represents the main vehicle of diffusion of the virus. The common and strong efforts to contain the pandemic have relevant effects on the management of samples from histopathology laboratories. The current commentary reports and focuses on the protocols and guidelines in use at a large tertiary Italian hospital that accordingly are proposed for adoption in Italian laboratories as a potential model for national guidelines for the coronavirus emergency.","Cancer Cytopathol","Rossi, Esther Diana","Fadda, Guido","Mule, Antonino","Zannoni, Gian Franco","Rindi, Guido","32259373"],"abstract":["The 2019 coronavirus pandemic, which started in Wuhan, China, spread around the globe with dramatic and lethal effects. From the initial Chinese epicenter, the European diaspora taxed the resources of several countries and especially those of Italy, which was forced into a complete social and economic shutdown. Infection by droplets contaminating hands and surfaces represents the main vehicle of diffusion of the virus. The common and strong efforts to contain the pandemic have relevant effects on the management of samples from histopathology laboratories. The current commentary reports and focuses on the protocols and guidelines in use at a large tertiary Italian hospital that accordingly are proposed for adoption in Italian laboratories as a potential model for national guidelines for the coronavirus emergency."],"journal":"Cancer Cytopathol","authors":["Rossi, Esther Diana","Fadda, Guido","Mule, Antonino","Zannoni, Gian Franco","Rindi, Guido"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259373","week":"202015|Apr 06 - Apr 12","doi":"10.1002/cncy.22281","keywords":["biosafety guidelines","coronavirus","cytology","fine-needle aspiration","histology","personalized medicine"],"source":"PubMed","locations":["Wuhan","Italy","italian","European","Italian","Chinese","China"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663450393513820160,"score":139.102},{"pmid":32275124,"title":"Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.","text":["Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.","The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. (c) 2020 International Society for Advancement of Cytometry.","Cytometry A","Cossarizza, Andrea","Gibellini, Lara","De Biasi, Sara","Lo Tartaro, Domenico","Mattioli, Marco","Paolini, Annamaria","Fidanza, Lucia","Bellinazzi, Caterina","Borella, Rebecca","Castaniere, Ivana","Meschiari, Marianna","Sita, Marco","Manco, Gianrocco","Clini, Enrico","Gelmini, Roberta","Girardis, Massimo","Guaraldi, Giovanni","Mussini, Cristina","32275124"],"abstract":["The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. (c) 2020 International Society for Advancement of Cytometry."],"journal":"Cytometry A","authors":["Cossarizza, Andrea","Gibellini, Lara","De Biasi, Sara","Lo Tartaro, Domenico","Mattioli, Marco","Paolini, Annamaria","Fidanza, Lucia","Bellinazzi, Caterina","Borella, Rebecca","Castaniere, Ivana","Meschiari, Marianna","Sita, Marco","Manco, Gianrocco","Clini, Enrico","Gelmini, Roberta","Girardis, Massimo","Guaraldi, Giovanni","Mussini, Cristina"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275124","week":"202015|Apr 06 - Apr 12","doi":"10.1002/cyto.a.24009","keywords":["Covid-19","SARS-CoV-2","biosafety","coronavirus","cytokines","cytometry"],"source":"PubMed","locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663712077962805248,"score":115.178604},{"pmid":32228808,"title":"Policy Decisions and Use of Information Technology to Fight 2019 Novel Coronavirus Disease, Taiwan.","text":["Policy Decisions and Use of Information Technology to Fight 2019 Novel Coronavirus Disease, Taiwan.","Because of its proximity to and frequent travelers to and from China, Taiwan faces complex challenges in preventing 2019 novel coronavirus disease (COVID-19). As soon as China reported the unidentified outbreak to the World Health Organization on December 31, 2019, Taiwan assembled a taskforce and began health checks onboard flights from Wuhan. Taiwan's rapid implementation of disease prevention measures helped detect and isolate the country's first COVID-19 case on January 20, 2020. Laboratories in Taiwan developed 4-hour test kits and isolated 2 strains of the coronavirus before February. Taiwan effectively delayed and contained community transmission by leveraging experience from the 2003 severe acute respiratory syndrome outbreak, prevalent public awareness, a robust public health network, support from healthcare industries, cross-departmental collaborations, and advanced information technology capacity. We analyze use of the National Health Insurance database and critical policy decisions made by Taiwan's government during the first 50 days of the COVID-19 outbreak.","Emerg Infect Dis","Lin, Cheryl","Braund, Wendy E","Auerbach, John","Chou, Jih-Haw","Teng, Ju-Hsiu","Tu, Pikuei","Mullen, Jewel","32228808"],"abstract":["Because of its proximity to and frequent travelers to and from China, Taiwan faces complex challenges in preventing 2019 novel coronavirus disease (COVID-19). As soon as China reported the unidentified outbreak to the World Health Organization on December 31, 2019, Taiwan assembled a taskforce and began health checks onboard flights from Wuhan. Taiwan's rapid implementation of disease prevention measures helped detect and isolate the country's first COVID-19 case on January 20, 2020. Laboratories in Taiwan developed 4-hour test kits and isolated 2 strains of the coronavirus before February. Taiwan effectively delayed and contained community transmission by leveraging experience from the 2003 severe acute respiratory syndrome outbreak, prevalent public awareness, a robust public health network, support from healthcare industries, cross-departmental collaborations, and advanced information technology capacity. We analyze use of the National Health Insurance database and critical policy decisions made by Taiwan's government during the first 50 days of the COVID-19 outbreak."],"journal":"Emerg Infect Dis","authors":["Lin, Cheryl","Braund, Wendy E","Auerbach, John","Chou, Jih-Haw","Teng, Ju-Hsiu","Tu, Pikuei","Mullen, Jewel"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228808","week":"202014|Mar 30 - Apr 05","doi":"10.3201/eid2607.200574","keywords":["2019 novel coronavirus disease","COVID-19","SARS","SARS-CoV-2","Taiwan","communicable diseases","coronavirus","data sharing","electronic medical records","emerging infectious diseases","epidemic","health policy","national health insurance","outbreak","pneumonia","public health","quarantine","respiratory infections","severe acute respiratory syndrome coronavirus 2","universal health care","viruses","zoonoses"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1663352135333445632,"score":79.94273},{"pmid":32202258,"title":"Guidance for building a dedicated health facility to contain the spread of the 2019 novel coronavirus outbreak.","text":["Guidance for building a dedicated health facility to contain the spread of the 2019 novel coronavirus outbreak.","Preparedness for the ongoing coronavirus disease 2019 (COVID-19) and its spread in India calls for setting up of adequately equipped and dedicated health facilities to manage sick patients while protecting healthcare workers and the environment. In the wake of other emerging dangerous pathogens in recent times, such as Ebola, Nipah and Zika, it is important that such facilities are kept ready during the inter-epidemic period for training of health professionals and for managing cases of multi-drug resistant and difficult-to-treat pathogens. While endemic potential of such critically ill patients is not yet known, the health system should have surge capacity for such critical care units and preferably each tertiary government hospital should have at least one such facility. This article describes elements of design of such unit (e.g., space, infection control, waste disposal, safety of healthcare workers, partners to be involved in design and plan) which can be adapted to the context of either a new construction or makeshift construction on top of an existing structure. In view of a potential epidemic of COVID-19, specific requirements to handle it are also given.","Indian J Med Res","Agarwal, Anup","Nagi, Nazia","Chatterjee, Pranab","Sarkar, Swarup","Mourya, Devendra","Sahay, Rima Rakeshkumar","Bhatia, Rajesh","32202258"],"abstract":["Preparedness for the ongoing coronavirus disease 2019 (COVID-19) and its spread in India calls for setting up of adequately equipped and dedicated health facilities to manage sick patients while protecting healthcare workers and the environment. In the wake of other emerging dangerous pathogens in recent times, such as Ebola, Nipah and Zika, it is important that such facilities are kept ready during the inter-epidemic period for training of health professionals and for managing cases of multi-drug resistant and difficult-to-treat pathogens. While endemic potential of such critically ill patients is not yet known, the health system should have surge capacity for such critical care units and preferably each tertiary government hospital should have at least one such facility. This article describes elements of design of such unit (e.g., space, infection control, waste disposal, safety of healthcare workers, partners to be involved in design and plan) which can be adapted to the context of either a new construction or makeshift construction on top of an existing structure. In view of a potential epidemic of COVID-19, specific requirements to handle it are also given."],"journal":"Indian J Med Res","authors":["Agarwal, Anup","Nagi, Nazia","Chatterjee, Pranab","Sarkar, Swarup","Mourya, Devendra","Sahay, Rima Rakeshkumar","Bhatia, Rajesh"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32202258","week":"202013|Mar 23 - Mar 29","doi":"10.4103/ijmr.IJMR_518_20","keywords":["Biocontainment","biosafety","coronavirus","designated health facility","infection prevention and control"],"source":"PubMed","locations":["India","Zika"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1663352133649432577,"score":67.09544},{"pmid":32259387,"title":"International perspectives: Impact of the COVID-19 Pandemic on cytology.","text":["International perspectives: Impact of the COVID-19 Pandemic on cytology.","Cancer Cytopathol","Rossi, Esther Diana","Pantanowitz, Liron","32259387"],"journal":"Cancer Cytopathol","authors":["Rossi, Esther Diana","Pantanowitz, Liron"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259387","week":"202015|Apr 06 - Apr 12","doi":"10.1002/cncy.22275","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1663450393462439937,"score":63.931213}]}